AMBA director awarded 2,498 RSUs; ownership now 41,779 shares
Christopher Paisley, a director of Ambarella, Inc. (AMBA), received an annual restricted stock unit (RSU) grant.
Rhea-AI Filing Summary
Christopher Paisley, a director of Ambarella, Inc. (AMBA), received an annual restricted stock unit (RSU) grant. The Board approved 2,498 RSUs on 09/02/2025. The RSUs vest in four equal quarterly installments beginning on a vesting start date of 09/15/2025 and are scheduled to be fully vested on 09/15/2026, subject to continued service. After the grant, Mr. Paisley beneficially owns 41,779 ordinary shares. The grant was reported on a Form 4 by an attorney-in-fact on behalf of Mr. Paisley.
Positive
- Director alignment: RSUs link the director's compensation to company equity, aligning interests with shareholders.
- Retention incentives: Quarterly vesting over a year encourages continued service through the next annual cycle.
Negative
- Dilution risk: Issuance of additional RSUs increases outstanding equity, though the filing does not quantify company-wide dilution.
- No performance conditions disclosed: Vesting is time-based only, not tied to performance metrics in this filing.
Insights
TL;DR: Routine annual director RSU grant aligning director incentives with long-term shareholder value.
The Board-approved award of 2,498 RSUs to an independent director is a common governance practice to tie non-employee director compensation to company performance and retention. The quarterly vesting over one year encourages continued service through the next annual cycle. This appears to be a standard, non-project-specific equity grant with no unusual acceleration or retention provisions disclosed.
TL;DR: Non-material issuance in isolation; modest ownership change for the reporting director.
The reported issuance increases the director's beneficial ownership to 41,779 shares. The grant size and one-year quarterly vesting are routine and provide modest additional alignment without indicating a major compensation shift. The filing does not disclose any cash price or expedited exercise, consistent with standard RSU awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 2,498 | $0.00 | $0.00 |
Footnotes (1)
- F1. Effective as of September 2, 2025, the Board of Directors approved an annual restricted stock unit grant of 2,498 Ordinary Shares to each independent director. The RSU grant vests as to 1/4th of the Ordinary Shares each three months following the vesting start date of September 15, 2025, so as to be 100% vested on September 15, 2026, subject to continued service with the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change in ownership did Christopher Paisley report for AMBA?
When do the RSUs awarded to the director vest?
Were any cash prices disclosed for the RSU grant in the Form 4?
Does the Form 4 indicate any performance conditions for the RSUs?
Who filed the Form 4 on behalf of Christopher Paisley?
AI-generated analysis. How Rhea-AI works. Not financial advice.